Transaction in Own Shares (Re

RNS Number : 5402V

GlaxoSmithKline PLC

29 May 2008

 



This announcement replaces the original announcement released on 28/05/08 at 16:51, RNS No: 4494V. The total number of shares in issue (excluding Treasury shares) should read 5,343,215,996 and not 5,342,675,996 shares as previously stated. All other details remain unchanged. The amended text appears below.

GlaxoSmithKline plc (the 'Company') announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 21 May 2008 it purchased 3,040,000 of its Ordinary shares of 25 pence each ('shares') on 28 May 2008 at a price of 1,117.79 pence per share. 

The shares will be cancelled. 

Following the cancellation of these shares, the Company holds 484,194,158 of its shares in Treasury, representing 9.06% of the total voting rights in the Company. 

The Company has 5,343,215,996 shares in issue (excluding Treasury shares). This number represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in the Company under the Financial Services Authority's Disclosure and Transparency Rules. 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer to purchase or subscribe for securities in any jurisdiction and is in conformity with the Financial Services Authority's Disclosure and Transparency Rules. 

 

END

 

 

POSPUUQUAUPRGCB